SCHEDULE 13G

CUSIP No.

1

Names of Reporting Persons

Callodine Capital Management, LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,505,165.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,505,165.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,505,165.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

11

Percent of class represented by amount in row (9)

5.96 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP No.

1

Names of Reporting Persons

James S. Morrow

2

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,505,165.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,505,165.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,505,165.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

11

Percent of class represented by amount in row (9)

5.96 %

12

Type of Reporting Person (See Instructions)

IN, HC

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

WOLVERINE WORLD WIDE INC

(b)

Address of issuer's principal executive offices:

9341 COURTLAND DRIVE N.E., ROCKFORD, Michigan, 49351

Item 2.

(a)

Name of person filing:

Callodine Capital Management, LP James S. Morrow Shares reported herein for Callodine Capital Management, LP ("Callodine") represent shares held for the benefit of investment advisory clients of Callodine. Shares reported herein for Mr. Morrow represent the above referenced shares reported for Callodine. Mr. Morrow is the managing member of the general partner of Callodine. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest therein.

(b)

Address or principal business office or, if none, residence:

Callodine Capital Management, LP James S. Morrow c/o Callodine Capital Management, LP Two International Place, Suite 1830 Boston, MA 02110

(c)

Citizenship:

Callodine Capital Management, LP - Delaware James S. Morrow - United States

(d)

Title of class of securities:

Common Stock, $1 par value

(e)

CUSIP No.:

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership

(a)

Amount beneficially owned:

4,505,165

(b)

Percent of class:

5.96%

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

0

(ii) Shared power to vote or to direct the vote:

4,505,165

(iii) Sole power to dispose or to direct the disposition of:

0

(iv) Shared power to dispose or to direct the disposition of:

4,505,165 The percentages reported herein with respect to the Reporting Persons' holdings are calculated based upon a statement in the Issuer's proxy statement, as filed with the Securities and Exchange Commission on March 26, 2026, that there were 81,980,999 shares of Common Stock, $1 par value, of the Issuer outstanding as of March 9, 2026.

Item 5.

Ownership of 5 Percent or Less of a Class.

Not Applicable

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Callodine Capital Management, LP

Signature:	By: Callodine Capital Management, LLC, Its General Partner, By: James S. Morrow, Managing Member
Name/Title:	/s/ James S. Morrow, Managing Member
Date:	05/15/2026

James S. Morrow

Signature:	/s/ James S. Morrow
Name/Title:	James S. Morrow
Date:	05/15/2026

Exhibit Information

Exhibit 99.1 - Joint Filing Statement